Primary Open Angle African-American Glaucoma Genetics Study Renewal
Primary Open Angle African-American Glaucoma Genetics Study Renewal
批准号:
10400065
负责人:
JOAN M O'BRIEN
金额:
$165.32万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-04-01 至 2026-03-31
关键词:
AddressAffectAfrican AmericanAfrican American populationAfrican ancestryAgeAmericanAuthorization documentationBilateralBiologicalBiological ModelsBlindnessCRISPR/Cas technologyCell Culture TechniquesCell modelCellsCitiesClinicalCodeCohort StudiesDNA sequencingDataDevelopmentDiseaseElectrophysiology (science)EnhancersEthnic groupEuropeanFamilial diseaseFundingGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic VariationGenetic studyGenomicsGenotypeGlaucomaGoalsIndividualInterventionLentivirus VectorMeta-AnalysisModelingMorphologyPathway interactionsPatientsPersonsPhasePhenotypePhiladelphiaPlayPopulationPrecision therapeuticsPredispositionPrevalencePrimary Open Angle GlaucomaPublic HealthRetinal Ganglion CellsRiskRoleSNP arraySpecialistStructureSusceptibility GeneSymptomsTarget PopulationsTestingTherapeutic InterventionTimeTrabecular meshwork structureUntranslated RNAVariantVisual impairmentblindburden of illnesscase controlcausal variantcohorteconomic outcomeendophenotypeexomeexome sequencingexperiencegene functiongenetic informationgenetic variantgenome editinggenome wide association studygenome-widegenome-wide analysisgenomic datahealth economicshuman datainduced pluripotent stem cellinterestloss of functionnoveloptic nerve disorderoverexpressionphenotypic datapolygenic risk scorepressurepromoterrare variantrecruitscreeningstructural genomicssuccesstraittranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary Statement
Primary open-angle glaucoma (POAG) represents a pressing public health problem in
African Americans. This disease is the leading cause of irreversible blindness in these
individuals. POAG affects African Americans more severely at earlier ages, contributing
to younger generations with vision loss and adverse health and economic outcomes.
Current pressure-lowering treatments for the disease have mixed success, with
approximately 30% of patients still experiencing vision loss. POAG is a familial disease
and there is a need for large genetic studies that elucidate disease mechanisms. This
need is especially pronounced in African Americans, who, despite their increased
burden of disease, remain seriously understudied. In its initial funding phase, the
Primary Open-Angle African American Glaucoma Genetics (POAAGG) study addressed
this disparity by conducting the largest-ever POAG genetics study on African Americans
recruited from a single city. For this renewal, we will study genetic data from a genome-
wide association study of 7765 subjects and whole-exome sequencing of 8082 subjects,
as well as rich phenotypic data on >90% of POAG cases. The proposed renewal will
allow us to further investigate and identify variants of biologic importance to African
American POAG. The aims of this study are: 1) to conduct post-GWAS analyses on
genome-wide significant variants from the POAAGG study to elucidate their role in this
disease, 2) to identify additional regions of interest for African American POAG through
whole-exome and structural genomics analyses, and 3) to evaluate the functional
impact of regions of interest in cellular model systems. Our findings will begin to define
relevant biologic pathways for African American POAG, which can potentially provide
targets for population screening and precision therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
-
批准号:8560079
-
项目类别:
-
资助金额:$226.38万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics Study Renewal
-
批准号:10668949
-
项目类别:
-
资助金额:$142.03万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
-
批准号:8815318
-
项目类别:
-
资助金额:$221.32万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6641270
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6910647
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7123301
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7250161
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7082066
-
项目类别:
-
资助金额:$62.64万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6544745
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6765946
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
海外基金